|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Marketed |
|---|
| Cancer | 4 | 5 | 2 | 6 | 1 | 0 | | Endocrine / Metabolic | 0 | 0 | 0 | 1 | 0 | 1 | | Neurology | 0 | 0 | 1 | 1 | 0 | 0 | | Ophthalmic | 0 | 0 | 0 | 2 | 0 | 0 |
|
|
Products Targeting Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)